XML 34 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 11 - Grants and Collaboration Revenue
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Government Grants and Contracts [Text Block]
11.
     Grants and Collaboration Revenue
 
We receive payments from government entities under our grants from the National Institute of Allergy and Infectious Diseases (NIAID) and from the U.S. Department of Defense in support of our vaccine research and development efforts. We record revenue associated with government grants as the reimbursable costs are incurred. During the
three
-month and
nine
-month periods ended
September 30, 2018,
we recorded
$340,716
and
$650,280,
respectively, of revenues associated with these grants, as compared to
$247,994
and
$800,866,
respectively, for the comparable periods of
2017.
As of
September 30, 2018,
there is an aggregate of
$2,873,542
in approved grant and contract funds available for use.
 
During the
three
-month and
nine
-month periods ended
September 30, 2018,
we recorded
$8,628
and
$13,628,
respectively, of revenues associated with research collaboration agreements with several
third
parties, as compared to $-
0
- and
$95,000,
respectively, for the comparable periods of
2017.